...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Private placement??

hummmmm,,,,,,,,,,if we are for sale at all especially here in the near term,,,,,, then,,,,,,,,,I think this company has three critical milestones which put a prospective buyer in wait mode,,,,,,,,,,,,1) awaiting more trial data from our oncology platform,  2) awaiting top line results from our BoM trial. or 3) awaiting the combination of both 1 & 2 !!,,,comments???

 

Share
New Message
Please login to post a reply